Kristian Reich Moon Lake Immunotherapeutics (MLTX) insider trading activity

MLTX Quotes by TradingView

Kristian Reich is Chief Scientific Officer of MoonLake Immunotherapeutics. Currently has a direct ownership of 84,367 shares of MLTX, which is worth approximately $3.97 Million. The most recent transaction as insider was on Jan 20, 2025, when has been sold 111,949 shares (Class C ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 84.4K
100.96% 3M change
57.02% 12M change
Total Value Held $3.97 Million

Kristian Reich Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 20 2025
SELL
Sale (or disposition) back to the issuer
-
111,949 Reduced 57.02%
84,367 Class C ordinary share...
Jan 20 2025
BUY
Conversion of derivative security
-
111,949 Added 42.11%
153,930 Class A ordinary share...
Feb 28 2024
SELL
Open market or private sale
$1,544,950 $55.0 p/Share
28,090 Reduced 40.09%
41,981 Class A ordinary share...
Feb 27 2024
SELL
Open market or private sale
$1,618,705 $55.0 p/Share
29,431 Reduced 29.58%
70,071 Class A ordinary share...
Feb 21 2024
SELL
Open market or private sale
$31,465 $55.3 p/Share
569 Reduced 0.57%
99,502 Class A ordinary share...
Feb 20 2024
SELL
Open market or private sale
$574,300 $57.43 p/Share
10,000 Reduced 9.09%
100,071 Class A ordinary share...
Feb 16 2024
SELL
Open market or private sale
$601,500 $60.15 p/Share
10,000 Reduced 8.33%
110,071 Class A ordinary share...
Feb 15 2024
SELL
Open market or private sale
$601,600 $60.16 p/Share
10,000 Reduced 7.69%
120,071 Class A ordinary share...
Feb 14 2024
SELL
Open market or private sale
$624,300 $62.43 p/Share
10,000 Reduced 7.14%
130,071 Class A ordinary share...
Oct 01 2023
SELL
Sale (or disposition) back to the issuer
-
41,981 Reduced 17.62%
196,316 Class C ordinary share...
Oct 01 2023
BUY
Conversion of derivative security
-
41,981 Added 23.06%
140,071 Class A ordinary share...
Apr 05 2023
SELL
Sale (or disposition) back to the issuer
-
98,090 Reduced 29.16%
238,297 Class C ordinary share...
Apr 05 2023
BUY
Conversion of derivative security
-
98,090 Added 50.0%
98,090 Class A ordinary share...
KR

Kristian Reich

Chief Scientific Officer
Zug, V8

Track Institutional and Insider Activities on MLTX

Follow MoonLake Immunotherapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MLTX shares.

Notify only if

Insider Trading

Get notified when an Moon Lake Immunotherapeutics insider buys or sells MLTX shares.

Notify only if

News

Receive news related to MoonLake Immunotherapeutics

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MLTX